Back to Authors

Vonk, Richardus

https://orcid.org/0009-0005-8356-9458

Mayo Clinic

Bayer Pharma AG, Berlin, Germany

Citations 1

Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial.
Teufel, Michael, Schwenke, Susanne, Beckmann, Georg, Reischl, Joachim, Vonk, Richardus , Lenz, Heinz‐Josef , Jeffers, Michael , Wilhelm, Scott M., Wagner, Andrea, Laurent, Dirk, Kobina, Svetlana, Rutstein, Mark, Wirapati, Pratyaksha , Seidel, Henrik , Tabernero, Josep , Siena, Salvatore , Grothey, Axel , Cutsem, Eric Van , Wagner, Andrea, Guinney, Justin , Tejpar, Sabine

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3558-3558

10.1200/jco.2015.33.15_suppl.3558 Get It